Varenicline N-dioxide HCl

Varenicline N-dioxide HCl is a prescription medication that is used to help people quit smoking. It is a partial agonist of the nicotinic acetylcholine receptor, which means that it binds to the receptor and activates it to a lesser extent than nicotine. This reduces the pleasurable effects of smoking and makes it easier for people to quit. Chemically, Varenicline N-dioxide HCl is a white to off-white crystalline powder that is soluble in water. It is also known as (2R,3R,4S)-3-(6,7-dihydro-1-methyl-1H-pyrazolo[4,3-d]pyrimidin-5-yl)-1-methyl-2-(2-oxido-2,3-dihydro-1H-inden-1-yl)pyrrolidine hydrochloride N-oxide. Varenicline N-dioxide HCl is typically taken orally, with a starting dose of 0.5 mg once daily for the first 3 days, followed by a maintenance dose of 1 mg twice daily. Treatment usually lasts for 12 weeks, but may be extended to 24 weeks in some cases. Side effects of Varenicline N-dioxide HCl may include nausea, headache, insomnia, and abnormal dreams. More serious side effects, such as depression or suicidal thoughts, are rare but may occur in some individuals. Overall, Varenicline N-dioxide HCl is an effective medication for smoking cessation that works by reducing the pleasurable effects of smoking. It is important to talk to a healthcare provider before starting treatment with Varenicline N-dioxide HCl to determine if it is the right choice for you.